Gerresheimer firmly on growth track
Gerresheimer AG is still on course for growth. "Our products, which improve health and well- being, are in high demand around the globe. Accordingly our revenue growth rates continue to be high", said Uwe Röhrhoff, CEO of Gerresheimer AG.
Gerresheimer has experienced marked growth in revenues in the third quarter of the 2012 financial year (December 1, 2011 to November 30, 2012) of 9.2 percent to EUR 311.4m. At constant exchange rates growth in revenues was 6.3 percent. All divisions contributed to this positive development.
Gerresheimer's operating result (adjusted EBITDA) was EUR 60.8m in the third quarter of 2012, which is EUR 3.7m or 6.5 percent higher than the figure for the same quarter of 2011. The adjusted EBITDA margin was 19.5 percent in the third quarter (prior year 20.0 percent). Net income declined due to one-off effects to EUR 14.4m, which is EUR 4.8m lower than the prior year quarter's figure. Third quarter earnings per share of EUR 0.62 were EUR 0.08 slightly lower than one year ago.
Outlook
Gerresheimer expects the growth of revenues in the financial year 2012 to be unchanged at 9 to 10 percent at constant exchange rates. The adjusted EBITDA margin forecast also remains the same at 19.5 percent. The company is still expecting the investment volume in the financial year 2012 to be around EUR 120m.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
